When did Myriad Genetics report Q4 2024 earnings?

Myriad Genetics (MYGN) reported Q4 2024 earnings on February 24, 2025 after market close.

What were Myriad Genetics's Q4 2024 revenue and EPS?

Myriad Genetics reported revenue of $210.6M and eps of $0.03 for Q4 2024.

Did Myriad Genetics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $210.3M by $251.4K. EPS beat the consensus estimate of $0.03 by $0.00.

Where can I find Myriad Genetics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000899923-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.

Myriad Genetics MYGN Q4 2024 Annual earnings

Reported February 24, 2025 · After market close

Revenue$210.6MBeat by $251.4K

EPS$0.03In line

Revenue estimate$210.3M

EPS estimate$0.03

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$206.0M

EPS estimate-$0.03

Financials

Q4 2024

Income statement

See full

Revenue$210.6M+7.1%

Gross profit$150.9M+11.8%

Operating income-$39.0M-24.2%

Net income-$42.5M-36.2%

EPS (diluted)-$0.47-38.2%

Balance sheet

See full

Cash & equivalents$111.9M-20.6%

Total debt$140.3M-7.8%

Total equity$701.1M-10.5%

Total assets$1.0B-10.4%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.25B-20.2%

Enterprise value$1.28B-19.0%

P/S1.5×-0.6×

Profitability

See full

Gross margin69.9%+1.2pp

Operating margin-14.7%-5.3pp

Net margin-15.2%-5.5pp

Returns & leverage

See full

Return on equity-17.2%-5.4pp

Debt / equity0.2×0.0×

Current ratio1.8×-0.2×

Segments

By product

See full

Hereditary Cancer$94.4M—

Prenatal$44.9M—

Versus estimates

Revenue

Q1 2026$200.4MMiss by $2.0M Q4 2025$209.8MBeat by $2.4M Q3 2025$205.7MMiss by $1.3M Q2 2025$213.1MBeat by $7.9M Q1 2025$195.9MMiss by $15.8M

Q4 2024$210.6MBeat by $251.4K

Diluted EPS

Q1 2026-$0.09Miss by $0.03 Q4 2025$0.04Beat by $0.06 Q3 2025-$0.13Miss by $0.12 Q2 2025$0.05Beat by $0.06 Q1 2025-$0.03Beat by $0.02

Q4 2024$0.03In line

Ask the moment Myriad Genetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Myriad Genetics report Q4 2024 earnings?: Myriad Genetics (MYGN) reported Q4 2024 earnings on February 24, 2025 after market close.
What were Myriad Genetics's Q4 2024 revenue and EPS?: Myriad Genetics reported revenue of $210.6M and eps of $0.03 for Q4 2024.
Did Myriad Genetics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $210.3M by $251.4K. EPS beat the consensus estimate of $0.03 by $0.00.
Where can I find Myriad Genetics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000899923-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.